StockMacro
Menu

Madrigal Pharmaceuticals

MDGL on XNAS, Madrigal Pharmaceuticals, Inc.

Measures activity, not value. Not investment advice.

Shares sold short (30 Oct 2026)

2.1M

-2.6% vs the report before

Short interest, % of shares outstanding

9.2%

23.2M shares outstanding (29 Oct 2026)

Days to cover

7.6

short interest / daily volume

Short sale volume share (20 Nov 2026)

39%

1-year median 58%

Sharp changes

3

short interest spike

Window
2.1M shares sold short on 30 Oct 2026, 9.2% of shares outstanding, 7.6 days to cover

FINRA short interest by settlement date (the 15th and the last business day of each month). FINRA publishes each report 7 business days after its settlement date. Dashed: 3-year median.

See the numbers
30 Oct 2026: 2.1M shares sold short, 7.6 days to cover
15 Oct 2026: 2.2M shares sold short, 7.2 days to cover
30 Sep 2026: 2.4M shares sold short, 9.8 days to cover
15 Sep 2026: 2.3M shares sold short, 11.4 days to cover
31 Aug 2026: 2.2M shares sold short, 9.5 days to cover
14 Aug 2026: 2.0M shares sold short, 6.0 days to cover
31 Jul 2026: 2.0M shares sold short, 4.8 days to cover
15 Jul 2026: 2.1M shares sold short, 6.9 days to cover
30 Jun 2026: 3.5M shares sold short, 6.2 days to cover
15 Jun 2026: 3.8M shares sold short, 14.3 days to cover
29 May 2026: 3.8M shares sold short, 14.1 days to cover
15 May 2026: 3.9M shares sold short, 12.3 days to cover
30 Apr 2026: 3.9M shares sold short, 16.5 days to cover
15 Apr 2026: 4.0M shares sold short, 12.7 days to cover
31 Mar 2026: 3.9M shares sold short, 9.1 days to cover
13 Mar 2026: 3.9M shares sold short, 13.9 days to cover
27 Feb 2026: 3.7M shares sold short, 8.2 days to cover
13 Feb 2026: 3.6M shares sold short, 11.1 days to cover
30 Jan 2026: 4.0M shares sold short, 12.7 days to cover
15 Jan 2026: 3.9M shares sold short, 9.8 days to cover
31 Dec 2025: 3.7M shares sold short, 13.1 days to cover
15 Dec 2025: 3.7M shares sold short, 14.0 days to cover
28 Nov 2025: 3.7M shares sold short, 10.0 days to cover
14 Nov 2025: 3.8M shares sold short, 7.4 days to cover
31 Oct 2025: 3.7M shares sold short, 12.7 days to cover
15 Oct 2025: 3.7M shares sold short, 13.9 days to cover
30 Sep 2025: 3.7M shares sold short, 10.9 days to cover
15 Sep 2025: 4.1M shares sold short, 12.8 days to cover
29 Aug 2025: 4.0M shares sold short, 9.3 days to cover
15 Aug 2025: 3.8M shares sold short, 8.4 days to cover
31 Jul 2025: 4.0M shares sold short, 8.8 days to cover
15 Jul 2025: 3.8M shares sold short, 16.0 days to cover
30 Jun 2025: 4.0M shares sold short, 12.2 days to cover
13 Jun 2025: 4.2M shares sold short, 13.9 days to cover
30 May 2025: 3.9M shares sold short, 12.1 days to cover
15 May 2025: 4.0M shares sold short, 10.3 days to cover
30 Apr 2025: 4.1M shares sold short, 11.4 days to cover
15 Apr 2025: 4.0M shares sold short, 11.5 days to cover
31 Mar 2025: 4.0M shares sold short, 17.0 days to cover
14 Mar 2025: 4.1M shares sold short, 8.5 days to cover
28 Feb 2025: 3.8M shares sold short, 8.7 days to cover
14 Feb 2025: 3.8M shares sold short, 10.7 days to cover
31 Jan 2025: 4.0M shares sold short, 8.6 days to cover
15 Jan 2025: 4.1M shares sold short, 9.0 days to cover
31 Dec 2024: 4.1M shares sold short, 12.6 days to cover
13 Dec 2024: 4.7M shares sold short, 16.0 days to cover
29 Nov 2024: 4.3M shares sold short, 11.3 days to cover
15 Nov 2024: 4.4M shares sold short, 5.4 days to cover
31 Oct 2024: 4.5M shares sold short, 12.5 days to cover
15 Oct 2024: 4.1M shares sold short, 14.4 days to cover
30 Sep 2024: 3.9M shares sold short, 13.8 days to cover
13 Sep 2024: 3.7M shares sold short, 17.9 days to cover
30 Aug 2024: 3.8M shares sold short, 20.0 days to cover
15 Aug 2024: 3.8M shares sold short, 9.8 days to cover
31 Jul 2024: 3.7M shares sold short, 14.1 days to cover
15 Jul 2024: 4.1M shares sold short, 16.3 days to cover
28 Jun 2024: 4.1M shares sold short, 10.1 days to cover
14 Jun 2024: 4.4M shares sold short, 5.6 days to cover
31 May 2024: 5.2M shares sold short, 13.2 days to cover
15 May 2024: 4.2M shares sold short, 9.9 days to cover

What the numbers say

  • 2.1M shares sold short on 30 Oct 2026, 9.2% of shares outstanding, 7.6 days to cover; -2.6% on the report before (published by FINRA on 10 Nov 2026).

Every measure from this source

Short interest is a position, reported twice a month. Short sale volume is a different measure: the share of each day's trading on off-exchange venues that was a short sale. Market makers sell short routinely, so 40% to 50% is normal.

Days to cover. 7.6 days in the report of 30 Oct 2026, 7.4 a year earlier.
Short interest, % of shares outstanding. 9.2% in the report of 30 Oct 2026, 17% a year earlier.
Daily short sale volume share on off-exchange venues. 39% of the off-exchange volume on 20 Nov 2026 was a short sale; its median of the last 12 months 58%. This is a daily flow, not short interest.

Sharp changes

3 in all loaded history, strongest first

Madrigal Pharmaceuticals had 5.2M shares sold short in the 31 May 2024 report, 3.6× the same report last year.

Short interest spike, became public on 12 Jun 2024

Same report last year: 1.5M; its normal report is 3.2M.

See the evidence
This period
5.2M (the 31 May 2024 report)
Normal report (median of 24 earlier)
3.2M
Typical spread (median absolute deviation)
272K
How far from its usual level
+5.0
Same report last year
1.5M
History used
2,345 days
2023-05-31: 1.5M2023-06-15: 1.6M2023-06-30: 1.8M2023-07-14: 1.9M2023-07-31: 1.8M2023-08-15: 1.8M2023-08-31: 2.0M2023-09-15: 2.1M2023-09-29: 2.6M2023-10-13: 3.0M2023-10-31: 3.4M2023-11-15: 3.5M2023-11-30: 3.5M2023-12-15: 3.1M2023-12-29: 3.3M2024-01-12: 3.3M2024-01-31: 3.1M2024-02-15: 3.4M2024-02-29: 3.5M2024-03-15: 3.3M2024-03-28: 3.4M2024-04-15: 3.4M2024-04-30: 4.0M2024-05-15: 4.2M2024-05-31: 5.2M
the 31 May 2024 report24 earlier reportsnormal: 3.2M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Madrigal Pharmaceuticals had 3.4M shares sold short in the 30 Apr 2020 report, 1.6× the same report last year.

Short interest spike, became public on 12 May 2020

Same report last year: 2.1M; its normal report is 2.5M.

See the evidence
This period
3.4M (the 30 Apr 2020 report)
Normal report (median of 24 earlier)
2.5M
Typical spread (median absolute deviation)
73K
How far from its usual level
+3.7
Same report last year
2.1M
History used
853 days
2019-04-30: 2.1M2019-05-15: 2.1M2019-05-31: 2.1M2019-06-14: 2.2M2019-06-28: 2.5M2019-07-15: 2.6M2019-07-31: 2.5M2019-08-15: 2.5M2019-08-30: 2.6M2019-09-13: 2.5M2019-09-30: 2.5M2019-10-15: 2.5M2019-10-31: 2.5M2019-11-15: 2.5M2019-11-29: 2.5M2019-12-13: 2.4M2019-12-31: 2.4M2020-01-15: 2.4M2020-01-31: 2.6M2020-02-14: 2.6M2020-02-28: 2.5M2020-03-13: 2.5M2020-03-31: 2.9M2020-04-15: 3.4M2020-04-30: 3.4M
the 30 Apr 2020 report24 earlier reportsnormal: 2.5M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Madrigal Pharmaceuticals had 3.4M shares sold short in the 15 Apr 2020 report, 1.7× the same report last year.

Short interest spike, became public on 25 Apr 2020

Same report last year: 2.0M; its normal report is 2.5M.

See the evidence
This period
3.4M (the 15 Apr 2020 report)
Normal report (median of 24 earlier)
2.5M
Typical spread (median absolute deviation)
74K
How far from its usual level
+3.7
Same report last year
2.0M
History used
838 days
2019-04-15: 2.0M2019-04-30: 2.1M2019-05-15: 2.1M2019-05-31: 2.1M2019-06-14: 2.2M2019-06-28: 2.5M2019-07-15: 2.6M2019-07-31: 2.5M2019-08-15: 2.5M2019-08-30: 2.6M2019-09-13: 2.5M2019-09-30: 2.5M2019-10-15: 2.5M2019-10-31: 2.5M2019-11-15: 2.5M2019-11-29: 2.5M2019-12-13: 2.4M2019-12-31: 2.4M2020-01-15: 2.4M2020-01-31: 2.6M2020-02-14: 2.6M2020-02-28: 2.5M2020-03-13: 2.5M2020-03-31: 2.9M2020-04-15: 3.4M
the 15 Apr 2020 report24 earlier reportsnormal: 2.5M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.